🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kevin Kim

University of Maryland, Baltimore

ORCID: 0009-0004-8227-2129

Also affiliated with La Jolla Institute for Immunology, BC Research (Canada), Occidental College

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF‐mutated cancers.

12 citations

James Moon, Christopher D. Lao, Bartosz Chmielowski, Kari Kendra, Karl D. Lewis +12 more

N/A
0DataRank · unranked
24 citations

Shani Aharon, Kevin Kim, Katerina Konstantinoff, Catherine M. Appleton, Dustin Stwalley +2 more

0 citations

An Bai, Michele Tomasicchio, James Hagman, Ashley M. Buckle, Arnav Gupta +14 more

58 citations

Kevin Kim, Haeuk Kim, Brendan Ha, Anaïs Gambiez, Jason W. Bennett +12 more

0 citations

Jason Greenbaum, Zhen Yan, Kevin Kim, Haeuk Kim, Ashmitaa Logandha Ramamoorthy Premlal +8 more